Welcome

Douglas T. Golenbock
Philipp Henneke

Dear friends and colleagues,

It is with great pleasure that we invite you to the TOLL2018 conference to be held from 6th to 9th June in Porto in Portugal.

Toll2018, like the previous five meetings, aims at displaying and challenging most recent developments in cellular innate immunity. Areas of particular interest are host-pathogen interactions, pattern recognition receptors, cellular signaling and immunometabolism, and myeloid cell development. Furthermore, we wish to explore the implications of improved knowledge in innate immune mechanisms for diagnosing and treating diseases.

The Toll meetings are all about communication and networking between a world class faculty, ranging from developmental biologists to translational scientists, and new and established researchers in the field.
Porto, the UNESCO World Heritage Site with its dramatic location along the Douro river, and the historic Alfandega congress center offer a wonderful environment for intense and lasting interactions.
We are looking forward to define – together with you – the leading edge in understanding and manipulating innate immunity.

Professor Douglas T. Golenbock MD
Department of Medicine
University of Massachusetts Medical School. USA
Professor Philipp Henneke MD
Center for Pediatrics &
Center for Chronic Immunodeficiency
Medical Center – University of Freiburg, Germany